MicroVision's SEC filings document material events for a lidar-based perception company serving automotive, industrial, and security and defense markets. Current reports describe operating results, business updates, investor presentations, and product and market disclosures tied to the company's lidar sensor portfolio and perception software.
Recent filings also record the completed acquisition of certain Luminar lidar sensor business assets, including required historical financial statements and unaudited pro forma financial information. Other disclosures cover senior secured convertible notes due 2028, exchanges and purchases of convertible debt, direct common stock sales to directors and executive officers, Nasdaq-related share issuance considerations, governance matters, and Regulation FD communications.
MicroVision, Inc. Interim CFO Stephen Hrynewich acquired 9,395 shares of common stock in a direct transaction with the company. The shares were purchased at $0.5322 per share, matching the closing price on March 13, 2026, under a Subscription Agreement executed on March 15, 2026.
After this acquisition, Hrynewich directly holds 172,092 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which governs certain insider transactions for reporting and short-swing profit purposes.
MicroVision, Inc. reported that all of its executive officers and U.S.-based board members have committed to purchase shares of the company’s common stock directly from the company. Pursuant to subscription agreements signed March 15, 2026, they will buy an aggregate of $310,000 of stock at $0.5322 per share, matching Friday’s Nasdaq closing price.
Because of regulatory considerations, these insider purchases are structured as direct issuances by MicroVision rather than open‑market buys, so the full proceeds go to the company. The purchased shares will be restricted, and the participating directors and executives will hold them until they cease to be affiliates, aligning their financial exposure with the company’s long‑term performance.
MICROVISION, INC. interim CFO Stephen Hrynewich reported equity compensation activity and related tax withholding. On March 5, 2026, 4,800 restricted stock units vested and converted on a unit-for-share basis into 4,800 shares of common stock at no cash cost to him.
These shares increased his directly held common stock to 164,256 shares. On March 6, 2026, 1,559 of those shares were disposed of through a withholding, nondiscretionary sell-to-cover transaction completed by the company to satisfy tax obligations, leaving him with 162,697 directly owned shares.
MicroVision, Inc. describes a lidar-focused business that remains in heavy investment mode, with substantial losses and a need for ongoing external funding. As of December 31, 2025, the company had an accumulated deficit of $957.3 million and recorded a $95.0 million net loss for 2025.
Results were hit by non-cash charges, including a $10.1 million impairment of perception software from the Ibeo acquisition, a $9.9 million MOVIA L inventory write-down, $2.2 million machinery impairment, and a $3.2 million adverse purchase commitment. Revenue remains concentrated in a few automotive and industrial customers and has recently declined with lost business.
The company is expanding its lidar portfolio through acquisitions of Ibeo assets in 2023 and, in 2026, Scantinel Photonics and Luminar’s worldwide lidar business, adding IRIS and HALO sensors and FMCW technology. This strategy increases operating costs and integration risk while MicroVision relies on securities purchase agreements and senior secured convertible notes to fund operations.
MicroVision warns it expects significant losses and negative cash flow through at least 2026 and will require additional capital beyond the next 12 months. It also discloses a Nasdaq minimum bid-price deficiency, potential dilution from convertible notes and equity issuance, and the risk of secured lenders foreclosing on its bank and securities accounts if it defaults.
MicroVision, Inc. reported fourth quarter and full year 2025 results showing a small revenue base and sizable losses as it transitions from R&D to commercial operations. Revenue was $223,000 for Q4 2025 and $1.2 million for the year, while net loss reached $37.8 million in Q4 and $95.0 million for 2025.
The company recorded significant non-cash charges, including a Q4 impairment loss on intangible assets of $10.1 million, plus impairments on lease right-of-use assets and property and equipment. Operating cash outflow for 2025 was $58.7 million, and cash, cash equivalents and restricted cash declined to $34.1 million as of December 31, 2025.
Management highlighted a strategic shift in early 2026, completing acquisitions of Luminar and Scantinel and beginning shipments on repeatable orders. To strengthen liquidity, MicroVision issued senior secured convertible notes with aggregate principal of $43.0 million, partly exchanging an existing note due March 2026, and retained access to an additional $43.0 million under an at-the-market equity facility.
MICROVISION, INC. director Robert Paul Carlile reported the vesting and conversion of restricted stock units into common shares. On this date, 22,007 RSUs were exercised at no cost and settled into 22,007 shares of common stock, bringing his directly held common stock to 350,799 shares.
The footnotes explain that RSUs convert into common stock on a unit-for-share basis without payment and clarify that a prior Form 4 understated the original RSU grant, with vesting now calculated from the corrected 88,028-unit grant.
MICROVISION, INC. director Laura J. Peterson reported the vesting of restricted stock units and their conversion into common shares. On March 2, 2026, 18,005 restricted stock units were exercised on a unit-for-share basis without payment, converting into 18,005 shares of common stock. After this conversion, Peterson directly owned 54,016 shares of MICROVISION common stock. The footnotes explain that RSUs convert into shares without cash outlay at vesting and that a separate RSU grant dated July 22, 2025 is scheduled to vest in four equal quarterly installments, subject to her continued board service.
MicroVision director Peter Schabert reported the vesting of restricted stock units that were converted into common shares. On the transaction date, 22,007 RSUs were distributed without payment and converted into 22,007 shares of common stock. Following this derivative exercise, he directly owns 146,471 common shares. A footnote explains that an earlier Form 4 had misstated the total RSUs granted in June 2025, and this vesting is based on the corrected grant amount.
MICROVISION, INC. director Jada Smith reported the vesting of restricted stock units that converted into common shares. On March 2, 2026, 22,007 RSUs were exercised at $0.00 per unit into 22,007 shares of common stock, bringing her direct common stock holdings to 126,358 shares.
MICROVISION, INC. director Jeffrey A. Herbst reported the vesting of 22,007 restricted stock units, which were converted into an equal number of common shares without payment on a unit-for-share basis. Following this non-cash derivative exercise, he directly holds 230,727 shares of common stock. A prior Form 4 is corrected here to state that the RSU grant on 06/05/2025 was 88,208 units, and the vesting disclosed was calculated from this corrected amount.